SPRAVATO® (Esketamine) Nasal Spray Approved in Europe for Adults with Treatment-Resistant Major Depressive Disorder - Business Wire

Submitted by Anonymous (not verified) on Thu, 12/19/2019 - 10:19

SPRAVATO® (Esketamine) Nasal Spray Approved in Europe for Adults with Treatment-Resistant Major Depressive Disorder  Business Wire